Use of exotoxin A to inhibit protein synthesis.
Saelinger
C B
CB
D036002:ADP Ribose Transferases; D000818:Animals; D001427:Bacterial Toxins; D005098:Exotoxins / Q000032:analysis / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D007202:Indicators and Reagents; D008722:Methods; D051379:Mice; D020652:Peptide Elongation Factor 2; D010445:Peptide Elongation Factors / Q000378:metabolism; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
D036002:ADP Ribose Transferases; D001427:Bacterial Toxins; D005098:Exotoxins; D007202:Indicators and Reagents; D020652:Peptide Elongation Factor 2; D010445:Peptide Elongation Factors; D011500:Protein Synthesis Inhibitors; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A